1 / 23

Gynie Goodies for the Generalist

Gynie Goodies for the Generalist. Kathleen J. Wilder, MD, MHS Chief, Department of Ob/Gyn Northern Navajo Medical Center Shiprock, NM October 30, 2010. Objectives. Learn to rapidly recognize the top 3 causes of vaginitis and know how to treat

laverne
Télécharger la présentation

Gynie Goodies for the Generalist

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Gynie Goodies for the Generalist Kathleen J. Wilder, MD, MHS Chief, Department of Ob/Gyn Northern Navajo Medical Center Shiprock, NM October 30, 2010

  2. Objectives • Learn to rapidly recognize the top 3 causes of vaginitis and know how to treat • Learn a quick and dirty work-up for menorrhagia and who needs it • Review the best treatment options for uncomplicated (female) UTIs • Make a case for perimenopausal hormone therapy • AMA contraception – see why it’s an urgent need and learn the best options • Wrap up with late/recent breaking tidbits

  3. Vaginitis/Vulvitis • Itching, burning, irritation, abnormal discharge, dysuria, postcoital bleeding… • Most common: • Candidiasis 17-39% • Baterialvaginosis 22-50% • Trichomoniasis 4-35% • Also: • Other STIs • Atrophic vaginitis • Undiagnosed 7-72% Vaginitis, ACOG practice bulletin #72, May 2006

  4. The Itch • Diagnosis • Microscopy – 50% sensitivity • So really….the story w/or w/o exam • Vagina and/or vulva • No vaginal bacterial cultures! • Etiology • Candida albicans • Anything that disturbs the normal vaginal pH balance • Douche, sex, late luteal phase… • Poorly controlled comorbidities -> DIABETES!!! Vaginitis, ACOG practice bulletin #72, May 2006

  5. Standard treatment • Antifungal cream PV QHS x 1 wk • Apply directly to affected area • “Complicated” infection (recurrent, severe, pregnancy, comorbidities, non-albicansCandida) • Diflucan 150mg po x 1 +/- antifungal cream • Diflucan x 2 - 72hrs apart +/- antifungal cream • Tx success increased from 67% to 80% • Recurrent • Fungal culture to check for non-albicansCandida Vaginitis, ACOG practice bulletin #72, May 2006

  6. The Odor • BV most common • Diagnosis – 2 or 3 of Amsel’s Criteria • Homogeneous grayish noninflammatory d/c (note missing LB) • Clue cells >20% • pH >4.5 • + Amine test -> Fishy odor w/KOH (frequently appreciated w/o) • Could also be other vaginitis – ex. Trich • Microscopy 50-60% sensitivity • Also pH >4.5 • Culture and Antigen tests have high sensitivity/specificity • Treatment – luckily the same! • Metronidazole 500mg po BID x 7 days Vaginitis, ACOG practice bulletin #72, May 2006

  7. A brief note about the vulva… • Thickening, pebbling, hypopigmentation, hyperpigmentation, thinning of the epithelium, lesions, non-healing lesions… • Anything irregular appearing needs biopsied Diagnosis and management of vulvar skin disorders, ACOG Practice Bulletin #93, May 2008.

  8. My periods are so heavy! • Menorrhagia = • >80ml/menstrual cycle OR • lasts for more than 7 days • Menometrorrhagia = • frequent menstrual bleeding that is excessive and irregular in amount and duration • Anovulatory Bleeding = • noncyclic menstrual blood flow that may range from spotty to excessive, is derived from the uterine endometrium, and is due to anovulatory sex steroid production specifically excluding an anatomic lesion • menstrual bleeding arising from anovulation or oligo-ovulation Management of anovulatory bleeding, ACOG practice bulletin #14, March 2000, reaffirmed 2009.

  9. Pathophysiology of Anovulatory Bleeding • No corpus luteum • No progesterone • Continued estrogen production Continuous unopposed estrogen stimulation ↓ Unsustainable endometrial growth

  10. Special Case Becoming the Norm: Obesity ↓ Androgens → Estrogens ↓ Chronic Anovulation

  11. What’s the big deal? • Endometrial cancer- based on 1995 data • 0.1/100,000 15-19yo • 9.5 19-35yo • 2.3 30-34yo • 6.1 35-39yo • 36.2 40-49yo SEER data 1973-1996

  12. Basic work-up: • Pregnancy test, TSH, prolactin, FSH • Ultrasound to r/o structural defect • Amenorrhea + negative/wnl results → Anovulation • Better to do the EMB than not do the EMB

  13. But don’t stop there… • Need therapy to • Prevent future episodes of acute hemorrhage • Prevent non-cyclic bleeding • Prevent future complications (i.e. cancer) • Improve quality of life • Initially HEAVY bleeding • May take ~3 cycles • Treatment options (depending on age) include: • Hormonal contraception - ex. COCs • Mirena IUD • Surgical intervention – endometrial ablation*, hysterectomy

  14. UTI (in females) • Diagnosis • Pyuria (>10) + bacteriuria • Don’t overdiagnose based on leukocyte esterase alone • FP due to dirty specimen or other infection such as yeast Treatment of urinary tract infections in nonpregnant women, ACOG Practice Bulletin #91, March 2008.

  15. UTI (in females) • It’s not just me, but a lot of really smart people say 3 days is enough…even if > 65 yo • Bactrim – totally great drug if resistance in your area is <15-20% --- 94% eradication rate • Fluoroquinolones – effective but not preferred first line tx • Amoxicillin/Ampicillin – NOT first line tx • 3 days is sufficient! • If macrobid (ex. pregnancy)—7 days • Resistance >15-20% necessitates change in antibiotic

  16. In order of preference: • TMP-sulfa DS 1 tab po BID x 3 days • Nitrofurantoin monohydrate macrocrystals 100mg po BID x 7 days • Ciprofloxacin 250mg po BID x 3 days • Levofloxacin 250mg po daily x 3 days

  17. Perimenopausal Issues • Transitional hormone therapy • AMA contraception Pazol K, Gamble, SB, Parker WY, et al. Abortion Surveillance –United States, 2006. In: Surveillance Summaries, November 27, 2009;58(S S08);1-35.

  18. Unwanted pregnancies among our AMA patients • Abortion rate among women aged <15 = 1.2/1000 women • Among women >40 = 2.6 per 1,000 women • Among women 35-39 = 7.8 per 1,000 women • Abortions among women >35yo account for 12.1% of all abortions • Slow but persistent increase over study period in women >35yo (up from 10.8%) • Abortion ratios highest at extremes of age

  19. Perimenopausal Hormone Management • Yes, there are some risks to HT • But for majority of women – it’s more good than bad!

  20. Who, When and How • Symptomatic • Hot flashes, vaginal dryness, poor sleep, poor moods • Menometrorrhagia → OLIGOovulatory bleeding • Combined hormonal birth control • Weigh pros and cons of risks and benefits • Take into account comorbidities • A word about botanicals… Schifren JL, Schiff I. Role of hormone therapy in the management of menopause. Obstet Gynecol 2010;115:839-55. Use of botanicals for management of menopausal symptoms. ACOG practice bulletin #28, June 2001, reaffirmed 2010.

  21. Transitional HT… • …Kill two birds with one stone: Perimenopausal estrogen withdrawal AND Prevent unplanned/unwanted pregnancy • If and when patient chooses hormone therapy after OCPs: • Smallest dose for shorter time • When decide to stop, do it slowly

  22. In Summary… • Better to biopsy than be biopsied (via wallet) • Vulvar and Endometrial biopsies • 3-2-1 Done!!! • The examined life is worth living and the unexamined and unmanaged postmenopausal life may NOT be worth living! • Help prevent unwanted AMA babies: Plan B + effective perimenopausal BCM

  23. Late or Recent Breaking Gyn Goodies: • No paps under 21yo • Every 2 – 3 years unless contraindicated • (HIV, hx CIN 2 or 3, immunocompromised, etc.) • New US based medical criteria for contraception • www.cdc.gov/mmwr • HPV vaccines – quadrivalent and bivalent • Approved for males and females 9 – 26 yo • Preconceptual mgmt of Diabetics - Folic acid 4mg/day • CDC STD treatment guidelines to come… • New recommendations for diagnosis of GDM to come… • …….

More Related